Original Articles“Incomplete Resection” in Non–Small Cell Lung Cancer: Need for a New Definition
Section snippets
Setting
We reviewed the records of patients presenting with apparently operable carcinoma of the lung who participated in a Canadian multicenter trial that enrolled 685 patients from November 1987 to September 1990 and followed up each patient for 3 years. Participating patients who had undergone a thoracotomy form the present study group. The primary results of this trial have been reported elsewhere [11].
Data Extraction
Two investigators independently reviewed the surgical record and pathologic reports of each
Study Population
Of the 685 patients randomized to either computed tomography or mediastinoscopy, 483 ultimately had a thoracotomy. Two-hundred two randomized patients did not have a thoracotomy for the following reasons [11]: 147 were deemed inoperable after the initial investigation, 8 declined operation, 18 had a medical contraindication to the operation, and 29 were diagnosed with a nonmalignant disease. We excluded 66 patients who did have a thoracotomy for the following reasons: exploratory thoracotomy
Comment
The results of this study challenge the current definition of an “incomplete resection,” which traditionally has included two pathologic findings, residual tumor at the resection margin or a positive highest mediastinal nodal station. Our clinicians considered a positive resection margin as an important risk factor for postoperative recurrence in NSCLC as reflected in its power in predicting ajuvant therapy. The finding that positive highest nodal station sampled at thoracotomy was not a
Acknowledgements
Doctors Guyatt and Cook are Career Scientists of the Ontario Ministry of Health. This study was supported by the Ontario Ministry of Health. Doctor Walter holds a National Health Scientist award from Health Canada.
References (26)
Current treatment of unresectable lung cancer
Mayo Clin Proc
(1993)Surgical therapy for carcinoma of the lung
Clin Chest Med
(1993)A new international staging system for lung cancer
Chest
(1986)- et al.
Prognosis and survival in resected lung carcinoma based on the new international staging system
J Thorac Cardiovasc Surg
(1988) The “incomplete resection”
Ann Thorac Surg
(1989)- et al.
Significance of metastatic disease on subaortic lymph nodes
Ann Thorac Surg
(1987) Expanded possibilities for surgical treatment of lung cancer—survival in stage IIIa disease
Chest
(1990)The bronchial spread of lung cancer
Br J Dis Chest
(1959)Synchronous primary lung cancers
Chest
(1993)- et al.
Carcinoma of the lungevaluation of satellite nodules as a factor influencing prognosis after resection
J Thorac Cardiovasc Surg
(1989)
Invasion of pulmonary arteries by bronchial carcinomas
Hum Pathol
Prognosis of residual invasive cancer at the margin of bronchial resection
Ann Thorac Surg
Survival with residual tumor on the bronchial margin after resection for bronchogenic carcinoma
J Thorac Cardiovasc Surg
Cited by (46)
Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery
2017, Lung CancerCitation Excerpt :In patients with non-small cell lung cancer (NSCLC), in the absence of distant metastasis, complete surgical resection continues to be the mainstay therapeutic modality. However, controversy exists about the definition of complete resection in NSCLC surgery [1–4] and inconsistencies regarding the impact of incomplete resection on prognosis further complicate matters [5–7]. In 2005, the International Association for the Study of Lung Cancer (IASLC) proposed several criteria to define complete and incomplete resection in NSCLC surgery taking into account pertinent literature and incorporating the concept of systematic nodal dissection [8].
Prevalence, prognostic implications, and survival modulators of incompletely resected non-small cell lung cancer in the U.S. National Cancer Data Base
2016, Journal of Thoracic OncologyCitation Excerpt :The role of chemotherapy in managing patients with positive margins is even less well defined because clinical trials of adjuvant chemotherapy typically exclude patients with positive resection margins.13,14 Practice guidelines in this area rely predominantly on expert opinion,3,5 contradictory single-institution reports,10,15–22 ad hoc secondary analyses of patient subsets in clinical trials designed to answer other questions,6 or literature reviews.11 We analyzed the U.S. National Cancer Data Base (NCDB) to establish the proportion of non-R0 resections in a contemporary multiyear national cohort.
Carcinoma in situ at the bronchial resection margin: A review
2011, Journal of Thoracic OncologyCitation Excerpt :CIS at the bronchial resection margin is only described in a very small percentage of the published series addressing the topic of residual disease at resection margins. A review of the English literature of the last 35 years contains 13 articles that included and/or described a number of cases with CIS at the bronchial margin.1–13 These series analyzed populations ranging from 255 to 4493 resected patients, and incidences of CIS at the margin varied from 0.02 to 2.4%.
Efficacy of mediastinal lymph node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy
2011, Annals of Thoracic Surgery
- 1
The members of the Canadian Lung Oncology Group are listed in Appendix A.